5-(Bromomethyl)-2-methylpyrimidin-4-amine hydrobromide, 95.0%, 250mg

Yohimbine Hydrochloride>99.0%(HPLC)(T)5g

2-Chloro-4-fluoro-3-methylbenzaldehyde, 95.0%, 5g

O-tert-Butyl-L-allo-threonine, 98.0%, 5g

(4-Methoxy-3,5-dimethylpyridin-2-yl)methyl acetate, 95.0%, 1g

Sotagliflozin, 99.89%, 10g

[4-Methyl-5-(4-piperidinyl)-4H-1,2,4-triazol-3-yl]methanol dihydrochloride hydrate, 95.0%, 250mg

2,5-Bis(2-ethylhexyl)-3,6-bis(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 95%, 100mg

2-tert-Butyloxycarbonylaminomethyl-5-thiophen-2-yl-[1,3,4]oxadiazole, 95.0%, 5g

(S)-Hexahydropyrrolo[1,2-a]pyrazine-1,4-dione, 95.0%, 2.5g

1-Phenylprop-2-en-1-one (Stabilized with 0.1% hydroquinone), 95.0%, 250mg

5-Bromo-7-fluoro-2,3-dihydro-1H-inden-1-one, 95.0%, 1g

trans-1-(tert-Butoxycarbonyl)-4-(3-fluorophenyl)pyrrolidine-3-carboxylic acid, 95.0%, 250mg